4//SEC Filing
Walker Neal 4
Accession 0001415889-25-002941
CIK 0001557746other
Filed
Feb 3, 7:00 PM ET
Accepted
Feb 4, 4:15 PM ET
Size
14.1 KB
Accession
0001415889-25-002941
Insider Transaction Report
Form 4
Walker Neal
DirectorCEO
Transactions
- Exercise/Conversion
Restricted Stock Units
2025-02-01−9,467→ 28,400 total→ Common Stock (9,467 underlying) - Exercise/Conversion
Common Stock
2025-02-01+9,467→ 1,464,277 total - Tax Payment
Common Stock
2025-02-01$2.48/sh−3,559$8,826→ 1,460,718 total - Award
Restricted Stock Units
2025-02-03+253,900→ 253,900 total→ Common Stock (253,900 underlying) - Award
Employee Stock Option (Right to Buy)
2025-02-03+888,800→ 888,800 totalExercise: $2.40Exp: 2035-02-02→ Common Stock (888,800 underlying)
Footnotes (5)
- [F1]Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer.
- [F2]The transaction reported represents the withholding of shares by the issuer to satisfy the Reporting Person's tax withholding obligations in connection with the vesting and settlement of restricted stock units described in this Form 4.
- [F3]The shares vest in equal monthly installments over 15 months beginning February 1, 2024, subject to the Continuous Service (as defined in the Plan) of the Reporting Person as the Interim CEO to the Company as of each such vesting date, provided that in the event he ceases to be Interim CEO but continues to provide Continuous Service in any capacity, such awards will continue to vest in the event that the Issuer's Board of Directors determines in its sole discretion that he achieved the Performance Goals (as defined in his letter agreement of employment as Interim CEO) prior to the cessation of his employment as Interim CEO.
- [F4]The shares underlying these restricted stock units vest in four equal installments on the first, second, third and fourth anniversaries of February 3, 2025, subject to the Continuous Service (as defined in the Plan) of the Reporting Person as of each such date.
- [F5]Exercisable with respect to 25% of the shares subject to the option vesting in four equal installments on the first, second, third and fourth anniversaries of February 3, 2025, subject to the Continuous Service (as defined in the Plan) of the Reporting Person as of each such date.
Documents
Issuer
Aclaris Therapeutics, Inc.
CIK 0001557746
Entity typeother
Related Parties
1- filerCIK 0001604457
Filing Metadata
- Form type
- 4
- Filed
- Feb 3, 7:00 PM ET
- Accepted
- Feb 4, 4:15 PM ET
- Size
- 14.1 KB